Men's Health News

0 16 6 minutes read

New Epigenetic Markers for Prostate Cancer Discovered

Oct. 3, 2022 — New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been …

Researchers Identify Drug Resistance Factors for Advanced Prostate Cancer

Sep. 22, 2022 — Researchers have identified critical genomic changes in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable and castration-resistant prostate …

Considering Genetic Risk in Prostate Cancer Referrals Could Lead to Earlier Diagnosis

Aug. 18, 2022 — A large-scale study looked at the impact of incorporating genetic risk for cancer into the GP triage and referral processes in the UK. The research concluded that considering genetic risk could …

Prostate Cancer Cases Risk Being Detected Too Late Due to Misleading Focus on Urinary Problems

Aug. 3, 2022 — Men with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines and media health campaigns focus on urinary symptoms despite a …

Prognosis of Prostate Cancer Patients Improved

July 18, 2022 — Prostate cancer is a common form of cancer. Researchers have now discovered a faster and easier way to determine who has an aggressive form of cancer, and who has …

Mechanism Leading to Drug Resistance in Prostate Cancer

June 15, 2022 — Researchers reveal a mechanism by which prostate cancer cells become resistant through molecular modification of the androgen receptor protein and identify a potential treatment approach that could …

High-Intensity Focused Ultrasound (HIFU) Can Control Prostate Cancer With Fewer Side Effects

June 15, 2022 — High-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or …

Hormones Contribute to Sex Disparities in Bladder Cancer, Study Shows

June 9, 2022 — Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new …

New Cancer Subtype May Illuminate Treatment Strategy

May 27, 2022 — Researchers have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth. This discovery opens the door to the …

How Tumor Cells Use Mitochondria to Keep Growing

May 10, 2022 — Investigators have discovered that tumor cells use mitochondria to control their growth and detect stress that can destroy a tumor cell if it is not …

Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases

Apr. 22, 2022 — Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men …

Novel Therapeutic Agents May Reduce the Oncogenesis of Metastatic Prostate Cancer

Apr. 13, 2022 — Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and homologous cyclin-dependent kinase 8 (CDK8) inhibitors reduces their potential to migrate …

Researchers Look to Licorice for Promising Cancer Treatments

Apr. 6, 2022 — A research review into molecular insights of a licorice-derived substance called glycyrrhizin for preventing or treating cancer suggests further research could lead to specific agents for clinical …

Cause of Metastasis in Prostate Cancer Discovered

Apr. 4, 2022 — Prostate cancers remain localized in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, …

Metastatic Prostate Cancer on the Rise Since Decrease in Cancer Screenings

Mar. 14, 2022 — A new study finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer …

New Risk Algorithm Would Improve Screening for Prostate Cancer

Mar. 8, 2022 — Researchers developed an algorithm estimating a person’s risk of developing prostate cancer based on age and the levels of two prostate cancer markers, PSA and hK2 (human kalliknein peptidase). …

Ultrasound Scan Can Diagnose Prostate Cancer

Feb. 28, 2022 — An ultrasound scan can be used to detect cases of prostate cancer, according to new …

Three-Drug Combination Prolongs Survival in Men With Metastatic, Hormone-Sensitive Prostate Cancer

Feb. 18, 2022 — Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy …

New Blood Test Combined With Image-Based Prostate Cancer Screening Reduces Harms and Costs

Jan. 28, 2022 — The combination of a novel blood test and magnetic resonance imaging (MRI) can reduce overdiagnosis of low-risk cancers as well as societal costs in prostate cancer screening, according to a …

Genetic Clues Link Lipoprotein A to Prostate Cancer Risk

Jan. 27, 2022 — A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein …

Monday, October 3, 2022